Link to this page
The Drug-Drug Interactions Ontology
Last uploaded:
February 11, 2016
| Id | http://purl.obolibrary.org/obo/dinto_0259
http://purl.obolibrary.org/obo/dinto_0259
|
|---|---|
| Preferred Name | receptor tyrosine-protein kinase erbb-2 |
| Synonyms |
receptor tyrosine-protein kinase erbb-2 precursor
c-erbb-2
mln 19
tyrosine kinase-type cell surface receptor her2
cd340 antigen
p185erbb2
neu proto-oncogene
ec 2.7.10.1
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| prefLabel | receptor tyrosine-protein kinase erbb-2
|
|---|---|
| label | receptor tyrosine-protein kinase erbb-2
|
| Definition | Essential component of a neuregulin-receptor complex, although neuregulins do not interact with it alone. GP30 is a potential ligand for this receptor. Not activated by EGF, TGF- alpha and amphiregulin
|
| type | |
| is inhibited by | |
| Synonym |
receptor tyrosine-protein kinase erbb-2 precursor
c-erbb-2
mln 19
tyrosine kinase-type cell surface receptor her2
cd340 antigen
p185erbb2
neu proto-oncogene
ec 2.7.10.1
See more
See less
|
| OrganismClass | human
|
| xref |
UniProt ID:P04626
DrugBank:567
|
| definition source | DrugBank Database
|
| prefixIRI | obo2:dinto_0259
|
| related with | |
| is pharmacological target of | |
| is blocked by | |
| Gene | erbb2
|
| subClassOf |
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |